Algert Global’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.97M Buy
375,080
+227,550
+154% +$773K 0.02% 834
2026
Q1
$260K Buy
+147,530
New +$320K ﹤0.01% 1043
2025
Q3
Sell
-95,533
Closed -$267K 1161
2025
Q2
$267K Sell
95,533
-159,890
-63% -$526K 0.01% 1056
2025
Q1
$917K Sell
255,423
-173,358
-40% -$696K 0.02% 786
2024
Q4
$1.35M Buy
428,781
+282,321
+193% +$1.01M 0.03% 720
2024
Q3
$413K Buy
+146,460
New +$335K 0.01% 940
2023
Q2
Sell
-11,881
Closed -$10K 1106
2023
Q1
$10K Buy
+11,881
New +$13K ﹤0.01% 1116
2022
Q4
Sell
-28,689
Closed -$49K 1151
2022
Q3
$49K Buy
+28,689
New +$75.1K ﹤0.01% 1135

Other funds holding CLOV

Algert Global's CLOV Position: Q2 2026 in Review

Algert Global increased its Clover Health Investments (CLOV) stake by 154% in Q2 2026, buying an estimated $773K and bringing the position to 375,080 shares worth $1.97M. The position accounts for 0.02% of the portfolio, ranked #834.

Algert Global first reported a position in CLOV in Q3 2022 and has held it in 8 quarters since. 225 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Algert Global held 375,080 shares of Clover Health Investments worth $1.97M as of Q2 2026.
  • Algert Global bought 227,550 Clover Health Investments shares in Q2 2026, an estimated $773K.
  • Clover Health Investments made up 0.02% of Algert Global's portfolio in Q2 2026, its #834 holding.
  • Algert Global first reported a position in Clover Health Investments in Q3 2022 and has held it in 8 quarters since.
  • 225 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.